Table: begin end state 1 27 cytoplasmic 28 48 transmembrane 49 52 non-cytoplasmic 53 72 transmembrane 73 80 cytoplasmic 81 104 transmembrane 105 288 non-cytoplasmic 289 312 transmembrane 313 323 cytoplasmic 324 348 transmembrane 349 378 non-cytoplasmic 379 402 transmembrane 403 431 cytoplasmic 432 455 transmembrane 456 491 non-cytoplasmic 492 514 transmembrane 515 521 cytoplasmic
Input: >WP_090447143.1 NCBI__GCF_900100495.1:WP_090447143.1 MTAMNAPAELASPAMPKYFSLPVLRKTLHWAVWGLFNALALYLVVALYAQQQIAFALLGL VVTGLASFIFISKKTYAHRYIYPALAGMLVFVIFPLLYTVGIGFTNYSGSNLLSFEQVQR YHLNQTYLAGERFAFSLHQDAAGALRLRVDQGEKGLFVSPPLQGDPALSEPLDLLPETSV SLGAALPLREVIQRRAELERWVLRGEQGELLRLYGLREVAAVKPLFRLLEDGDLQNTRSG EVLSADQDIGFYVDSHGAKVAPGFTVYAGASNFAKVLTDPSIRAPFLEIFVWTVAFAGLT VLFTLAVGLLLASLLQWDLVGGKAFYRVMLILPYAVPAFISILVFRGLFNQNFGEINLLL DSLFGMRPDWFSDPTLARGMILLVNTWLGYPYMLLLCMGLLQAIPRDLYEASAMDGATPL DNLLKITLPLLIKPLAPLLIASFAFNFNNFVLITLLTRGGPDIIGATTPAGTTDLLVSYT YRIAFQDSGQNFALAAAIATLIFLVVGGMAWLNLKLSKVKV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server